Introducing PartoMa Approach in Ethiopia to Improve Intrapartum Care and Maternal Survival
Using Continuous Fetal Heart Rate Monitoring and Locally Adapted Guidelines
Led by Haramaya Unversity · Updated on 2024-02-22
500
Participants Needed
2
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the PartoMa approach, which includes locally agreed and achievable intrapartum care guidelines and a continuous in-house training program, to improve decision making during labor in Eastern Ethiopia. This study aims to introduce this approach along with continuous fetal heart rate monitoring using the MOYO device to reduce perinatal mortality and improve outcomes for mothers and newborns at two busy hospitals.
The study is organized in four phases baseline assessment, co-creation of context-specific intrapartum care guidelines, implementation of PartoMa seminars and fetal heart rate monitoring, and post-intervention evaluation. The PartoMa seminars and low dose high frequency trainings are introduced after adapting guidelines from Tanzania to fit the local setting. Health providers will use continuous fetal heart rate monitoring with the MOYO device to support decision making during labor.
Participants include laboring women delivering at the study sites and health care providers. Women and their newborns will be followed until discharge. Researchers will collect data through interviews, observations, and record reviews to assess fetal heart rate monitoring practices, guideline compliance, and pregnancy outcomes. Key outcomes include stillbirth, birth asphyxia, maternal death, cesarean sections, and quality of intrapartum care. The study runs from June 2023 to May 2025 with ongoing monitoring and evaluation throughout.
CONDITIONS
Brief Title
Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach
Research Team
A
Abera Tura, PhD
H
Habtamu Bekele, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Women in labor delivering at the study sites during July - September 2023 and July - September 2025
Birth attendants working in the obstetrics and gynecology departments during the baseline and intervention periods, July - September 2023 and July - September 2025
You will not qualify if you...
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Screening and enrollment visit
Baseline Assessment
Duration - 3 months
Participants experience a baseline assessment of current intrapartum care practices, including interviews, record reviews, and observations over three months.
Ongoing observations and assessments during the baseline period
Co-creation of PartoMa Guidelines
Duration - 3 months
Participants and local birth attendants collaborate to adapt intrapartum care guidelines specific to the hospital context over three months.
Meetings and guideline development sessions
Implementation of PartoMa Intervention
Duration - 12 months
Participants receive PartoMa seminars, low-dose high-frequency training, and supportive supervision to improve intrapartum care.
PartoMa seminars and training sessions during the intervention period
Post-intervention Evaluation
Duration - 6 months
Participants undergo evaluation of the impact and sustainability of the PartoMa intervention using similar tools as baseline.
Data collection and assessments similar to baseline
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
The PEARL Trial Evaluating Lactated Ringers Amnioinfusion to Protect Newborns from Respiratory Problems and Support Development After Meconium Exposure
How Assisted Reproductive Technologies Influence Pregnancy and Newborn Outcomes
A Multicenter Study Comparing Singleton and Multiple Pregnancies
Randomized Trial on Antibiotic Treatment of Asymptomatic Bacteriuria in Pregnant Women in Low- and Middle-Income Countries to Reduce Preterm Birth and Stillbirth
Aspirin 150 mg to Prevent Complications in Pregnant Women with Chronic Hypertension
A Multicenter Randomized Double-Blind Placebo-Controlled Phase 3 Trial
Community-based Digital Support Using Two-Way SMS to Improve Newborn Health and Reduce Neonatal Death in Western Kenya
Pilot Study Evaluating the Womb Watch Smartphone Application for Monitoring Fetal Movements in Pregnant Women
Monitoring Heart Electrical Activity in High-Risk Pregnancies to Detect Risks of Fetal Death Using Fetal Magnetocardiography and Neonatal ECG
Introducing PartoMa Approach in Ethiopia to Improve Intrapartum Care and Maternal Survival
Using Continuous Fetal Heart Rate Monitoring and Locally Adapted Guidelines
Study of Influenza and COVID-19 Impact on Pregnant Women and Babies in India
Observing Pregnancy Outcomes and Infection Risks
At Government Medical College Hospital, Nagpur
Study of a Structured Ultrasound Program for Monitoring Fetal Growth and Reducing Stillbirth Risks in Pregnant Women at Oxford University Hospitals
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Coadaptation and implementation of intrapartum clinical guidelines to save lives during childbirth: Protocol for an adapted PartoMa intervention in Eastern Ethiopia.
Habtamu Bekele, Thomas van den Akker, Nanna Maaloe...